MCYAX
Price
$16.68
Change
-$0.48 (-2.80%)
Updated
Jul 2 closing price
Net Assets
130.04M
RNWEX
Price
$105.05
Change
-$1.94 (-1.81%)
Updated
Jul 2 closing price
Net Assets
90.88B
Interact to see
Advertisement

MCYAX vs RNWEX

MCYAX vs RNWEX Comparison Chart in %
View a ticker or compare two or three
VS
MCYAX vs. RNWEX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCYAX is a StrongBuy and RNWEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 90.9B vs. MCYAX (130M). RNWEX pays higher dividends than MCYAX: RNWEX (0.97) vs MCYAX (0.72). MCYAX was incepted earlier than RNWEX: MCYAX (9 years) vs RNWEX (24 years). MCYAX (1.74) is less costly to investors than RNWEX (0.92). MCYAX is a more actively managed with annual turnover of: 189.00 vs. RNWEX (46.00). RNWEX has a lower initial minimum investment than MCYAX: RNWEX (250) vs MCYAX (15000). MCYAX annual gain was more profitable for investors over the last year : 44.41 vs. RNWEX (20.11). MCYAX return over 5 years is better than : 26.49 vs. RNWEX (13.51).
MCYAXRNWEXMCYAX / RNWEX
Total Expense Ratio1.500.92163%
Annual Report Gross Expense Ratio1.740.92189%
Fund Existence9 years24 years-
Gain YTD26.55513.518196%
Front Load6%N/A-
Min. Initial Investment150002506,000%
Min. Initial Investment IRAN/AN/A-
Net Assets130M90.9B0%
Annual Yield % from dividends0.720.9775%
Returns for 1 year44.4120.11221%
Returns for 3 years85.2546.99181%
Returns for 5 years26.4913.51196%
Returns for 10 yearsN/A113.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX75.922.19
+2.97%
Rydex Biotechnology A
AMFFX64.230.40
+0.63%
American Funds American Mutual F1
ACGQX24.660.07
+0.28%
Invesco Growth and Income R5
SMVFX12.95-0.13
-0.99%
Virtus Ceredex Mid-Cap Value Equity C
HFCGX36.45-0.80
-2.15%
Hennessy Cornerstone Growth Investor